Showing results (511-520 of 615) with videos related to

Sort By:
Pageof 62
Journal of Cardiovascular Electrophysiology|June 14, 2019
Catheter ablation of atrial fibrillation in patients with heart failure with reduced ejection fraction: Real world experience from six European centersRui Providência, Carlo de Asmundis, Julian Chun, et al.
Heart Rhythm|March 15, 2025
Dual-chamber leadless pacemaker implant procedural outcomes: Insights from the AVEIR DR i2i studyRahul N Doshi, James E Ip, Pascal Defaye, et al.
ESC Heart Failure|January 18, 2024
Pre-emptive treatment of heart failure exacerbations in patients managed with the HeartLogic™ algorithmRodrigue Garcia, Daniel Gras, Jacques Mansourati, et al.
Heart Rhythm|May 20, 2026
Clinical Validation of an In-Silico Pace Mapping Approach to Localize both Focal and Reentrant Ventricular Arrhythmias in Patients with Structural Heart DiseaseFernando O Campos, Ursula Rohrer, Sri Kousthubha Allampalli, et al.
Circulation. Arrhythmia and Electrophysiology|March 27, 2025
One-Year Safety and Performance of a Dual-Chamber Leadless PacemakerReinoud E Knops, James E Ip, Rahul Doshi, et al.
Journal of Electrocardiology|October 4, 2020
Prognostic significance of a low T/R ratio in Brugada syndromeAntoine Delinière, Adrian Baranchuk, Francis Bessière, et al.
Heart Rhythm|July 11, 2025
Atrial fibrillation progression in patients with device-detected subclinical atrial fibrillation: Insights from the ARTESiA trialGiuseppe Boriani, William F McIntyre, Chinthanie Ramasundarahettige, et al.
International Journal of Cardiology|January 22, 2019
Subcutaneous implantable cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy: Results from an Italian multicenter registryFederico Migliore, Stefano Viani, Maria Grazia Bongiorni, et al.
Heart Rhythm|April 16, 2017
The QUIDAM study: Hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic riskAntoine Andorin, Jean-Baptiste Gourraud, Jacques Mansourati, et al.
Heart Rhythm|October 12, 2017
Implantable cardioverter-defibrillator-computed respiratory disturbance index accurately identifies severe sleep apnea: The DASAP-HF studyAntonio D'Onofrio, Maria Teresa La Rovere, Michele Emdin, et al.
Pageof 62